The immunohistochemistry market is projected to reach USD 2.12 Billion by 2021, growing at a CAGR of 7.3% during the forecast period. Rising geriatric population, growing prevalence of chronic diseases, rapid technological developments in the IVD industry, and increasing healthcare spending are expected to fuel the growth of this market in the coming years. However, rapid growth in the developing countries across APAC and Latin America and the increasing demand for personalized medicine are expected to offer significant growth opportunities for players in the market. Regulatory restrictions in developed countries, however, are a major challenge faced by market players in the current market.

The global immunohistochemistry market is segmented based on product, application, end user, and region. Based on product, the market is segmented into antibodies, reagents, equipment, and kits. Based on application, the global market is segmented into diagnostics and drug testing. The global market for diagnostic applications is further segmented into infectious diseases, cancer, cardiovascular diseases, diabetes mellitus, autoimmune diseases, and nephrological diseases. On the basis of end user the market is segmented into hospitals and diagnostics laboratories, research institutes, and other end users. This report also provides market information across major regional segments, namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. These regions are further segmented at a country level.

The antibodies segment accounted for the largest share of the global immunohistochemistry market, by product. On the other hand, the kits segment is expected to grow at the highest rate during the forecast period. Factors such as high demand for complete solutions from a single provider and advantages of kits such as ease of use, availability of ready-to-use reagents and antibodies, optimized sensitivity of the antibody to the antigen, and decreased chances of errors are driving the growth of this segment.

The major players in the immunohistochemistry market are F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (U.S.), Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Merck Millipore (U.S.), Bio-Rad Laboratories, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Abcam plc (U.K.), Cell Signaling Technology, Inc. (U.S.), and Bio SB Inc. (U.S.).

For More Info Click@ http://www.marketsandmarkets.com/Market-Reports/immunohistochemistry-market-121632939.html